Evidence to support the use of statins for preventing recurrent cardiovascular disease (CVD) is strong, derived from individual patient data meta-analysis1 and from systematic reviews of randomized trials.2 This evidence underpins the use of statins in clinical guidelines internationally as an uncontroversial treatment for secondary prevention that is both cost-effective and safe.3-5